Literature DB >> 12202584

Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda.

S Niemann1, S Rüsch-Gerdes, M L Joloba, C C Whalen, D Guwatudde, J J Ellner, K Eisenach, N Fumokong, J L Johnson, T Aisu, R D Mugerwa, A Okwera, S K Schwander.   

Abstract

The population structure of 234 Mycobacterium tuberculosis complex strains obtained during 1995 and 1997 from tuberculosis patients living in Kampala, Uganda (East Africa), was analyzed by routine laboratory procedures, spoligotyping, and IS6110 restriction fragment length polymorphism (RFLP) typing. According to biochemical test results, 157 isolates (67%) were classified as M. africanum subtype II (resistant to thiophen-2-carboxylic acid hydrazide), 76 isolates (32%) were classified as M. tuberculosis, and 1 isolate was classified as classical M. bovis. Spoligotyping did not lead to clear differentiation of M. tuberculosis and M. africanum, but all M. africanum subtype II isolates lacked spacers 33 to 36, differentiating them from M. africanum subtype I. Moreover, spoligotyping was not sufficient for differentiation of isolates on the strain level, since 193 (82%) were grouped into clusters. In contrast, in the IS6110-based dendrogram, M. africanum strains were clustered into two closely related strain families (Uganda I and II) and clearly separated from the M. tuberculosis isolates. A further characteristic of both M. africanum subtype II families was the absence of spoligotype spacer 40. All strains of family I also lacked spacer 43. The clustering rate obtained by the combination of spoligotyping and RFLP IS6110 analysis was similar for M. africanum and M. tuberculosis, as 46% and 49% of the respective isolates were grouped into clusters. The results presented demonstrate that M. africanum subtype II isolates from Kampala, Uganda, belong to two closely related genotypes, which may represent unique phylogenetic branches within the M. tuberculosis complex. We conclude that M. africanum subtype II is the main cause of human tuberculosis in Kampala, Uganda.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202584      PMCID: PMC130701          DOI: 10.1128/JCM.40.9.3398-3405.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997.

Authors:  D van Soolingen; M W Borgdorff; P E de Haas; M M Sebek; J Veen; M Dessens; K Kremer; J D van Embden
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

2.  Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients.

Authors:  S Lockman; J D Sheppard; C R Braden; M J Mwasekaga; C L Woodley; T A Kenyon; N J Binkin; M Steinman; F Montsho; M Kesupile-Reed; C Hirschfeldt; M Notha; T Moeti; J W Tappero
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

3.  Differentiation among members of the Mycobacterium tuberculosis complex by molecular and biochemical features: evidence for two pyrazinamide-susceptible subtypes of M. bovis.

Authors:  S Niemann; E Richter; S Rüsch-Gerdes
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  Quantitative bacillary response to treatment in Mycobacterium tuberculosis infected and M. africanum infected adults with pulmonary tuberculosis.

Authors:  M L Joloba; J L Johnson; A Namale; A Morrissey; A E Assegghai; S Rüsch-Gerdes; R D Mugerwa; J J Ellner; K D Eisenach
Journal:  Int J Tuberc Lung Dis       Date:  2001-06       Impact factor: 2.373

5.  Genetic diversity of Mycobacterium africanum clinical isolates based on IS6110-restriction fragment length polymorphism analysis, spoligotyping, and variable number of tandem DNA repeats.

Authors:  C Viana-Niero; C Gutierrez; C Sola; I Filliol; F Boulahbal; V Vincent; N Rastogi
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

6.  Differentiation of clinical Mycobacterium tuberculosis complex isolates by gyrB DNA sequence polymorphism analysis.

Authors:  S Niemann; D Harmsen; S Rüsch-Gerdes; E Richter
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

7.  Evolution and clonal traits of Mycobacterium tuberculosis complex in Guinea-Bissau.

Authors:  G Källenius; T Koivula; S Ghebremichael; S E Hoffner; R Norberg; E Svensson; F Dias; B I Marklund; S B Svenson
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

8.  Transmission dynamics of tuberculosis in a high-incidence country: prospective analysis by PCR DNA fingerprinting.

Authors:  W H Haas; G Engelmann; B Amthor; S Shyamba; F Mugala; M Felten; M Rabbow; M Leichsenring; O J Oosthuizen; H J Bremer
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

9.  What is the meaning of repeated isolation of Mycobacterium africanum?

Authors:  D Bonard; P Msellati; L Rigouts; P Combe; D Coulibaly; I M Coulibaly; F Portaels
Journal:  Int J Tuberc Lung Dis       Date:  2000-12       Impact factor: 2.373

10.  Analysis of rate of change of IS6110 RFLP patterns of Mycobacterium tuberculosis based on serial patient isolates.

Authors:  A S de Boer; M W Borgdorff; P E de Haas; N J Nagelkerke; J D van Embden; D van Soolingen
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

View more
  32 in total

1.  Is Mycobacterium africanum subtype II (Uganda I and Uganda II) a genetically well-defined subspecies of the Mycobacterium tuberculosis complex?

Authors:  Christophe Sola; Nalin Rastogi; M Cristina Gutierrez; Véronique Vincent; Roland Brosch; Linda Parsons
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

2.  Molecular characterization and drug resistance testing of Mycobacterium tuberculosis isolates from Chad.

Authors:  Colette Diguimbaye; Markus Hilty; Richard Ngandolo; Hassane H Mahamat; Gaby E Pfyffer; Franca Baggi; Marcel Tanner; Esther Schelling; Jakob Zinsstag
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

3.  Spoligotype profile of Mycobacterium tuberculosis complex strains from HIV-positive and -negative patients in Nigeria: a comparative analysis.

Authors:  Simeon Cadmus; Véronique Hill; Dick van Soolingen; Nalin Rastogi
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

Review 4.  Exploring the usefulness of molecular epidemiology of tuberculosis in Africa: a systematic review.

Authors:  Bourahima Kone; Anou M Somboro; Jane L Holl; Bocar Baya; Antieme Acg Togo; Yeya Dit Sadio Sarro; Bassirou Diarra; Ousmane Kodio; Robert L Murphy; William Bishai; Mamoudou Maiga; Seydou Doumbia
Journal:  Int J Mol Epidemiol Genet       Date:  2020-06-15

5.  PCR-based method to differentiate the subspecies of the Mycobacterium tuberculosis complex on the basis of genomic deletions.

Authors:  Richard C Huard; Luiz Claudio de Oliveira Lazzarini; W Ray Butler; Dick van Soolingen; John L Ho
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

6.  Molecular evolutionary history of tubercle bacilli assessed by study of the polymorphic nucleotide within the nitrate reductase (narGHJI) operon promoter.

Authors:  Khye Seng Goh; Nalin Rastogi; Mylène Berchel; Richard C Huard; Christophe Sola
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

7.  Genetic diversity of Mycobacterium tuberculosis in Mbarara, South Western Uganda.

Authors:  J Bazira; M Matte; B B Asiimwe; L M Joloba
Journal:  Afr Health Sci       Date:  2010-12       Impact factor: 0.927

8.  The T2 Mycobacterium tuberculosis genotype, predominant in Kampala, Uganda, shows negative correlation with antituberculosis drug resistance.

Authors:  Deus Lukoye; Fred A Katabazi; Kenneth Musisi; David P Kateete; Benon B Asiimwe; Moses Okee; Moses L Joloba; Frank G J Cobelens
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

9.  Distinct genotypic profiles of the two major clades of Mycobacterium africanum.

Authors:  Sidra E Gonçalves Vasconcellos; Richard C Huard; Stefan Niemann; Kristin Kremer; Adalberto R Santos; Philip N Suffys; John L Ho
Journal:  BMC Infect Dis       Date:  2010-03-29       Impact factor: 3.090

10.  Mycobacteria causing human cervical lymphadenitis in pastoral communities in the Karamoja region of Uganda.

Authors:  J Oloya; J Opuda-Asibo; R Kazwala; A B Demelash; E Skjerve; A Lund; T B Johansen; B Djonne
Journal:  Epidemiol Infect       Date:  2007-06-29       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.